NIFTYHEALTHCAREINDEX · NSE

Nifty Healthcare

Index · View only — not on the trading terminal

₹16,613.9

+0.51% (+₹84.75)

Prev. close

₹16,529.15

Volume

3,59,26,512

As of

18 Sept 2026

Price history

Not enough intraday ticks yet — try again once trading is underway.

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Nifty Healthcare in the last 90 days.

Index metrics

As of 19 Sept, 04:19 IST

Open

16,547.55

Day High

16,690.4

Day Low

16,545.05

Prev. Close

16,529.15

52W High

16,941.7

52W Low

13,536.5

P/E

43.53

P/B

5.38

Div. Yield

0.46%

Member stocks today

How many of this index's member stocks rose or fell today — a broad move and a few-heavyweights move look very different here.

Rose

Fell

Flat

Composition

20 stocks · 15 advanced · 5 declined

Member stocks, ranked by index weight — heaviest first.

Top weight: SUNPHARMA · 17.1% (free-float mcap share, estimate — not NSE’s published weight)

StockWeightPrice · Day

ETFs tracking this index

4 funds

Index levels are informational only, not investment advice.

LUPIN

Lupin Share Price Rises 2.52%: Price, Valuation, Peer View

Univest · 13 hours ago

MAXHEALTH

Max Healthcare Institute Share Price rises 2%

Univest · 14 hours ago

DIVISLAB

Caplin Point Laboratories Share Price rises 5.18% today

Univest · 15 hours ago

TORNTPHARM

Emcure Pharmaceuticals Share Price news after 2.42% gain

Univest · 19 hours ago

SUNPHARMA

Taro Pharmaceutical Industries stock gains on Sun Pharma merger cash offer

Taro Pharmaceutical Industries stock is gaining as a cash merger with Sun Pharmaceutical Industries is finalized. Shareholders will receive $32.25 per share as of September 17, 2026, converting equity into a fixed cash payout. This move aligns with Sun Pharma's strategy to consolidate subsidiaries and streamline its corporate structure.

1 day ago·Read at AD HOC NEWS

LAURUSLABS

Is Laurus (LAURUSLABS.NS) Still a Buy After +2.24% Rally? 2026-09-17 - VOLD Alert

siam.in · 1 day ago

FORTIS

Fortis moves Supreme Court against Delhi High Court order

The Times of India · 1 day ago

LUPIN

Lupin Share Price rises 2.04%: valuation, peers, sector

Univest · 2 days ago

ALKEM

Alkem Laboratories Ltd spurts 2.36%

Business Standard · 2 days ago

DRREDDY

Dr Reddy's Laboratories Q1 2027 Earnings Call Transcript

Benzinga · 2 days ago

LAURUSLABS

Laurus Labs Share Price Today: 2.46% Rise and Valuation

Univest · 2 days ago

FORTIS

Fortis Healthcare shares rise over 3% in early deals; here's why

businesstoday.in · 2 days ago

MANKIND

Mankind Pharma Q2 FY27 Earnings Preview

Mankind Pharma's Q2 FY27 earnings date is not yet confirmed, though Indian regulations require results by November 14, 2026. The company's stock traded at Rs 2,250.00 on September 17, 2026, up 0.18%. Investors will compare Q2 FY27 results against Q1 FY27 net profit of Rs 574.00 crore and Q2 FY26 profit of Rs 520.00 crore.

2 days ago·Read at Univest

AUROPHARMA

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

The Economic Times · 3 days ago

TORNTPHARM

Emcure Pharmaceuticals Share Price: Fundamentals and Fall

Univest · 3 days ago

AUROPHARMA

Aurobindo Pharma shares fall 2% after USFDA issues one observation for Telangana facility

Moneycontrol.com · 3 days ago

DRREDDY

Dr Reddy's Laboratories Ltd (RDY) Shares Fall 3.0% -- What GF Sc